Keyword: biotech industry

News

Myriad Wins Gene Patent Ruling from US Appeals Court

16.08.2012 - A federal appeals court on Thursday revived its decision to uphold Myriad Genetics's patents on two genes linked to breast and ovarian cancer, after the U.S. Supreme Court told it...

News

Molecular Profiles, Onyx Scientific to Cooperate

13.08.2012 - Molecular Profiles, a specialist contract research and manufacturing organisation, announced that it has entered into a strategic alliance with Onyx Scientific, a contract...

News

Biotech M&A at 4-Year High as Pharma Faces Expiring Patents

03.08.2012 - Global biotech merger volume has reached levels not seen in four years as big pharmaceutical companies pursue deals to get access to new drugs, with bankers saying therapeutic...

News

U.S. Appeals Court Reconsiders Myriad Gene Patent Ruling

21.07.2012 - Myriad Genetics illegally patented acts of nature when it claimed ownership of two genes linked to cancer, the federal government told an appeals court on Friday. Lawyers from...

News

Cost Cuts Help Actelion Lift Earnings View

19.07.2012 - Actelion raised its earnings outlook for 2012 on Thursday as cost cuts helped Europe's biggest biotech company to post a first-half profit despite its most important drug facing...

News

Surge in Biotech Deals to Unlock Big Investor Profits

18.07.2012 - Large investors in U.S. biotech companies are likely to capture serious windfall profits as deal activity picks up in the sector. A Reuters analysis of investors' average cost...

News

DSM, Recepta Announce Contract Manufacturing Agreement

18.07.2012 - DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, announced that it has signed a biologics contract manufacturing agreement with its first...

News

After Roche Merger, Biotech Tail Wags Big Pharma Dog

03.07.2012 - When Roche paid $46.8 billion in 2009 to gain full ownership of Genentech, fears were rife that the arrival of the Swiss men in suits would stifle the free-wheeling innovative...